- Home
- TURN vs ANEB Comparison
TURN vs ANEB Comparison
Compare TURN & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TURN
- ANEB
- Stock Information
- Founded
- TURN 1981
- ANEB 2020
- Country
- TURN United States
- ANEB United States
- Employees
- TURN N/A
- ANEB N/A
- Industry
- TURN Finance/Investors Services
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- TURN Finance
- ANEB Health Care
- Exchange
- TURN Nasdaq
- ANEB Nasdaq
- Market Cap
- TURN 39.9M
- ANEB 39.0M
- IPO Year
- TURN N/A
- ANEB 2021
- Fundamental
- Price
- TURN $4.02
- ANEB $1.04
- Analyst Decision
- TURN
- ANEB Strong Buy
- Analyst Count
- TURN 0
- ANEB 2
- Target Price
- TURN N/A
- ANEB $5.50
- AVG Volume (30 Days)
- TURN 27.0K
- ANEB 11.7K
- Earning Date
- TURN 06-10-2025
- ANEB 05-13-2025
- Dividend Yield
- TURN N/A
- ANEB N/A
- EPS Growth
- TURN N/A
- ANEB N/A
- EPS
- TURN N/A
- ANEB N/A
- Revenue
- TURN $194,813.00
- ANEB N/A
- Revenue This Year
- TURN N/A
- ANEB N/A
- Revenue Next Year
- TURN N/A
- ANEB N/A
- P/E Ratio
- TURN N/A
- ANEB N/A
- Revenue Growth
- TURN 254.25
- ANEB N/A
- 52 Week Low
- TURN $3.12
- ANEB $0.80
- 52 Week High
- TURN $4.25
- ANEB $3.08
- Technical
- Relative Strength Index (RSI)
- TURN 53.43
- ANEB 45.52
- Support Level
- TURN $3.91
- ANEB $1.00
- Resistance Level
- TURN $4.18
- ANEB $1.15
- Average True Range (ATR)
- TURN 0.25
- ANEB 0.08
- MACD
- TURN -0.01
- ANEB 0.01
- Stochastic Oscillator
- TURN 46.51
- ANEB 37.77
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.